Buy Tirzepatide in New York — $125/Month | Trimi Health
GLP-1 weight loss treatment in New York — compounded tirzepatide shipped directly to your New York address in 2–3 business days. No clinic visits, no insurance required, just $125/month.
More on GLP-1 by Location
Why New York Residents Choose Tirzepatide via Telehealth
Tirzepatide — the active ingredient in Mounjaro and Zepbound — has emerged as one of the most effective weight loss medications ever studied. Clinical trials demonstrated approximately 22% body weight loss over 72 weeks, making it a powerful option for New York residents struggling with obesity. However, brand-name tirzepatide costs $1,000–$1,400 per month without insurance, and local New York clinics typically charge $400–800 per month for compounded versions.
Trimi offers compounded tirzepatide at $125/month — delivered directly to any New York address through telehealth. No clinic visit, no insurance, no prior authorization. For New York residents, this represents a significant cost savings compared to both brand-name and clinic-based options.
New York Tirzepatide Snapshot
Population: ~8.3 million city / ~20 million metro. Typical clinic cost: $400–800/mo. Brand Zepbound: $1,000–$1,400/mo. Trimi telehealth: $125/mo tirzepatide, $99/mo semaglutide.
Learn more about how telehealth prescribing works, read our semaglutide vs. tirzepatide comparison, or explore Ozempic vs. Wegovy.
New York Pricing: Trimi vs Local Providers & Pharmacies
| Option | Monthly Cost | In-Person Visit | Insurance Required |
|---|---|---|---|
| New York Weight Loss Clinic (avg) | $400–$800 | Yes | Sometimes |
| New York Pharmacy (brand Zepbound) | $1,000–$1,400 | Yes | Recommended |
| Trimi Telehealth (compounded) | $125/mo (tirz) / $99/mo (sema) | No | No |
Interested in semaglutide instead? Read our detailed comparison to decide which medication is right for you.
How It Works: 3 Steps to Get Tirzepatide in New York
Step 1: Online Health Intake
Complete a health questionnaire covering your medical history, medications, BMI, and weight loss goals — from anywhere in New York.
Step 2: Provider Review & Prescription
A licensed provider evaluates your submission, confirms candidacy for tirzepatide, and sends your prescription to a licensed compounding pharmacy.
Step 3: Delivered to Your New York Door
Temperature-controlled packaging arrives at your New York address within 3–5 business days. Monthly refills ship automatically.
Check our GLP-1 candidacy guide to see if you qualify for tirzepatide.
Available Medications for New York Residents
Compounded Tirzepatide
$125/month
- Same active ingredient as Mounjaro/Zepbound
- Dual GLP-1/GIP receptor agonist
- ~22% average weight loss at 72 weeks
- No insurance required
Compounded Semaglutide
$99/month
- Same active ingredient as Wegovy
- Weekly self-injection
- ~15% average weight loss at 68 weeks
- No insurance required
Learn about compounded medication safety, read about your first month of treatment, and check our GLP-1 weight loss timeline.
Getting Started with Tirzepatide in New York
New York residents with a BMI of 27+ (with a weight-related condition) or 30+ may qualify for tirzepatide treatment through Trimi. Whether you're in Brooklyn, Queens, or Jersey City or anywhere in the greater New York area, medication ships directly to your door.
Read about managing GLP-1 side effects, explore our semaglutide vs. tirzepatide comparison, or see diet tips while on GLP-1 medications.
Ready to Start Tirzepatide in New York?
Get compounded tirzepatide delivered to any New York address for $125/month. No office visit, no insurance, no waiting room.
Get Started for $125/MonthFrequently Asked Questions: Tirzepatide in New York
Can I get tirzepatide in New York without visiting a clinic?
Yes. Trimi offers compounded tirzepatide entirely through telehealth. New York residents complete an online health intake, receive a provider evaluation, and get medication shipped directly to their New York address — no in-person visit required.
How much does tirzepatide cost at New York weight loss clinics?
New York-area weight loss clinics in neighborhoods like Upper East Side, SoHo, and Westchester typically charge $400–800 per month for compounded tirzepatide programs. Brand Zepbound costs $1,000–$1,400/month without insurance. Trimi delivers compounded tirzepatide for $125/month.
How fast is tirzepatide shipping to New York?
Most New York residents receive their compounded tirzepatide within 3–5 business days after prescription approval. Medication ships directly to your New York address — whether you're in Brooklyn, Queens, or Jersey City.
What is the difference between tirzepatide and semaglutide?
Tirzepatide is a dual GLP-1/GIP receptor agonist, while semaglutide targets only GLP-1 receptors. Clinical trials showed tirzepatide produced approximately 22% body weight loss at 72 weeks compared to 15% for semaglutide at 68 weeks. Trimi offers both: semaglutide at $99/month and tirzepatide at $125/month for New York residents.
Is telehealth prescribing for tirzepatide legal in New York?
Yes. New York law permits licensed providers to conduct telehealth evaluations and prescribe medications including GLP-1 agonists like tirzepatide. Trimi connects New York residents with licensed providers who manage care entirely online.
Is compounded tirzepatide the same as Mounjaro or Zepbound?
Compounded tirzepatide contains the same active ingredient as Mounjaro and Zepbound but is prepared by a licensed compounding pharmacy at a fraction of the brand-name cost. It is not an FDA-approved branded product but is legally prescribed under federal compounding regulations.
Can I continue tirzepatide treatment if I move within the New York area?
Yes. Because Trimi is a telehealth program, your care is tied to your account — not a clinic location. Whether you move within New York or to a nearby suburb like Stamford or Hoboken, your treatment continues without interruption.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Tirzepatide and semaglutide are prescription medications requiring evaluation by a licensed healthcare provider. Individual results vary. Common side effects include nausea, vomiting, diarrhea, and constipation. Not appropriate for individuals with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
Sources & References
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- New York City Public Health Department. Community Health Assessment 2023.
- FDA Prescribing Information for Zepbound (tirzepatide) and Wegovy (semaglutide).